BioPharma Dive December 9, 2024
Sponsored content By Almac Clinical Services
Contract development and manufacturing in the Asia-Pacific (APAC) market is poised for explosive growth. The region has been the focus of significant expansion, and the market size is expected to top $108 billion by 2029.Outsourcing trends, increased healthcare expenditure and demand for injectable drugs and cell and gene therapies have made clinical services organizations integral to drug development value chains.
Clinical services organizations help pharmaceutical manufacturers manage growing regulatory complexities, high development costs and increased competition. This enables pharma companies to focus on their core competencies, says Kevin Cheong, Clinical Operations Director APAC for Almac Group.
“Pharmaceutical companies should prioritize research and development—rather than being bogged down by supply chain logistics, supply chain...
Today's Sponsors
Today's Sponsor